Control of Systemic Inflammation and Chronic Diseases-The Use of Turmeric and Curcuminoids

Nutrigenomics and Proteomics in Health and Disease: Food Factors and Gene Interactions

Volumn , Issue , 2009, Pages 161-180

  Bengmark, Stig ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Critical illness (CI) and chronic diseases (ChDs); Curcuma longa traditional remedy for gastritis and gastric ulcer; Curcumenoids recommended for skin diseases from acne to psoriasis; Curcumin in acute and chronic diseases; Dietary bioactive food components interacting with immune response potential to reduce risk of cancer; oral cavity diseases similarities in periodontal diseases and RA pathogenesis; TNF related apoptosis inducing ligand (TRAIL); Turmeric approved as food additive

Indexed keywords

EID: 78650183663     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813807263.ch12     Document Type: Chapter

References (172)

1. Abuarqoub H, Green CJ, Foresti R, and Motterlini R. 2007. Curcumin reduces cold storage-induced damage in human cardiac myoblasts. Exp Mol Med. 39:139-481.
2. Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S, and Sethi G. 2007. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol. 73:1024-1032.
3. Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, and Ichikawa H. 2006a. Targeting signal-transducer-and-activator-oftranscription- 3 for prevention and therapy of cancer: Modern target but ancient solution. Ann N Y Acad Sci. 1091:151-169.
4. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, and Price JE. 2005. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res. 11:7490-7498.
5. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, and Aggarwal BB. 2006b. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol. 69:195-206.
6. Amit S and Ben-Neriah Y. 2003. NF-kappaB activation in cancer: A challenge for ubiquitinationand proteasome-based therapeutic approach. Semin Cancer Biol. 13:15-28.
7. Angus DC, Linde-Zwirble WT, and Lidicker J. 2001. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome and associated costs of care. Crit Care Med. 29:1303-1310.
8. Antony S, Kuttan R, and Kuttan G. 1999. Immunomodulatory activity of curcumin. Immunol Invest. 28:291-303.
9. Apisariyakul A, Vanittanakom N, and Buddhasukh D. 1995. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol. 49:163-169.
10. Arias E and Smith BL. 2003. Deaths: Preliminary data for 2001. Natl Vital Stat Rep. 51:1-44.
11. Atsumi T, Fujisawa S, and Tonosaki K. 2005. Relationship between intracellular ROS production and membrane mobility in curcumin- and tetrahydrocurcumin-treated human gingival fibroblasts and human submandibular gland carcinoma cells. Oral Dis. 11:236-242.
12. Bachmeier B, Nerlich AG, Iancu CM, Cilli M, Schleicher E, Vené R, Dell'Eva R, Jochum M, Albini A, and Pfeffer U. 2007. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem. 19:137-152.
13. Bala K, Tripathy BC, and Sharma D. 2006. Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology. 7:81-89.
14. Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, Alam J, and Motterlini R. 2003. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J. 371:887-895.
15. Baptista JAB and Carvalho RCB. 2004. Indirect determination of Amadori compounds in milk-based products by HPLC/ELSD/UV as an index of protein deterioration. Food Res Internat. 37:739-747.
16. Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C et al. 2008. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. 28:110-113.
17. Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F,Ciapparelli A, Dell'Osso L, and Bombardieri S. 2007. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol. 25:225-230.
18. Began G, Sudharshan E, Udaya Sankar K, and Appu Rao AG. 1999. Interaction of curcumin with phosphatidylcholine: A spectrofluorometric study. J Agric Food Chem. 47:4992-4997.
19. Bengmark S. 2004. Acute and "chronic" phase response-A mother of disease. Clin Nutr. 23:1256-1266.
20. Bengmark S. 2006a. Bioecological control of inflammation and infection in critical illness. Anaesthesiol Clin North Amer. 24:299-323.
21. Bengmark S. 2006b. Curcumin: An atoxic antioxidant and natural NF-κB, COX-2, LOX and iNOS inhibitor-A shield against acute and chronic diseases. J Parenter Enteral Nutr JPEN. 30:45-51.
22. Bengmark S. 2007. Advanced glycation and lipoxidation end products-Amplifiers of inflammation: The role of food. J Parent Ent Nutr JPEN. 31:430-440.
23. Bengtsson U, Knutson TW, Knutson L, Dannaeus A, Hällgren R, and Ahlstedt S. 1996. Increased levels of hyaluronan and albumin after intestinal challenge in adult patients with cow's milk intolerance. Clin Exp Allergy. 26:96-103.
24. Bernes PJ and Karin M. 1997. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 336:1066-1071.
25. Bharti AC, Donato N, and Aggarwal BB. 2003. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol. 171:3863-3871.
26. Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R, Raj-Vadhan S, Estrov Z, Talpaz M, and Aggarwal BB. 2004. Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood. 103:3175-3184.
27. Bhaumik S, Jyothi MD, and Khar A. 2000. Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett. 483:78-82.
28. Bravani Shankar TN, Shantha NV, Ramesh HP, Murthy IA, and Murthy VS. 1980. Toxicity studies on Turmeric (Curcuma longa): Acute toxicity studies in rats, guinea pigs & monkeys. Indian J Exp Biol. 18:73-75.
29. Brouet I and Ohshima H. 1995. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun. 206:533-540.
30. Calabrese V, Butterfield DA, and Stella AM. 2003. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: Novel targets for neuroprotection in Alzheimer's disease. Ital J Biochem. 52:177-181.
31. Calabrese V, Guagliano E, Sapienza M, Mancuso C, Butterfield DA, and Stella AM. 2006. Redox regulation of cellular stress response in neurodegenerative disorders. Ital J Biochem. 55:263-282.
32. Calabrese V, Guagliano E, Sapienza M, Panebianco M, Calafato S, Puleo E, Pennisi G, Mancuso C, Butterfield DA, and Stella AG. 2007. Redox regulation of cellular stress response in aging and neurodegenerative disorders: Role of vitagenes. Neurochem Res. 32:757-773.
33. Camacho-Barquero L, Villegas I, Sánchez-Calvo JM, Talero E, Sánchez-Fidalgo S, Motilva V, and Alarcón de la Lastra C. 2007. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol. 7:333-342.
34. Chakravarti N, Myers JN, and Aggarwal BB. 2006. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int J Cancer. 119:1268-1275.
35. Chang D-M. 2001. Curcumin: A heat shock response inducer and potential cytoprotector. Crit Care Med. 29:2231-2232.
36. Charles V and Charles SX. 1992. The use and efficacy of Azadirachta indica ADR ('Neem') and Curcuma longa ('Turmeric') in scabies. A pilot study. Trop Geogr Med. 44:178-181.
37. Chen HW, Kuo HT, Chai CY, Ou JL, and Yang RC. 2007. Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia. J Endotoxin Res. 13:15-23.
38. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W et al. 2001. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21:2895-2900.
39. Cho ML, Jung YO, Moon YM, Min SY, Yoon CH, Lee SH, Park SH, Cho CS, Jue DM, and Kim HY. 2006. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunol Lett. 103:159-166.
40. Chun KS, Keum YS, Han SS, Song YS, Kim SH, and Surh YJ. 2003. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis. 24:1515-1524.
41. Churchill M, Chadburn A, Bilinski RT, and Bertagnolli MM. 2000. Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res. 89: 169-175.
42. Deeb D, Jiang H, Gao X, Al-Holou S, Danyluk AL, Dulchavsky SA, and Gautam SC. 2007. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6- heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2 L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. J Pharmacol Exp Ther. 321:616-625.
43. Deeb DD, Jiang H, Gao X, Divine G, Dulchavsky SA, and Gautam SC. 2005. Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. J Exp Ther Oncol. 5:81-91.
44. Deitch EA, Shorshtein A, Houghton J, Lu Q, and Xu D. 2002. Inducible nitric oxide synthase knockout mice are resistant to diet-induced loss of gut barrier function and intestinal injury. J Gastrointest Surg. 6:599-605.
45. Deodhar SD, Sethi R, and Srimal RC. 1980. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res. 71:632-634.
46. Di Mario F, Cavallaro LG, Nouvenne A, Stefani N, Cavestro GM, Iori V, Maino M, Comparato G, Fanigliulo L, Morana E et al. 2007. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: Something to learn from failure?. Helicobacter. 12:238-243.
47. Dunsmore KE, Chen PG, and Wong HR. 2001. Curcumin, a medicinal herbal compound capable of inducing the heat shock response. Crit Care Med. 29:2199-2204.
48. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glöckner-Pagel J, Canny S, Du K, Lukacs GL, and Caplan MJ. 2004. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science. 304:600-602.
49. Emanuele E, Elia C, and Venturini L. 2007. Potential usefulness of curcumin in cystic fibrosis. Med Hypotheses. 69:222-223.
50. Ferguson LR and Philpott M. 2007. Cancer prevention by dietary bioactive components that target the immune response. Curr Cancer Drug Targets. 7:459-464.
51. Flynn DL, Rafferty MF, and Boctor AM. 1986. Inhibition of human neutrophil 5- lipooxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostaglandins Leukot Med. 24:195-198.
52. Foryst-Ludwig A, Neumann M, Schneider-Brachert W, and Naumann M. 2004. Curcumin blocks NF-κB and the mitogenic response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Com. 316:1065-1072.
53. Fugh-Berman A. 2002. Herb-drug interactions. Lancet. 355:134-138.
54. Gaedeke J, Noble NA, and Border WA. 2004. Curcumin blocks multiple sites of the TGF-ß signaling cascade in renal cells. Kidney International. 66:112-120.
55. Ganguly K, Kundu P, Banerjee A, Reiter RJ, and Swarnakar S. 2006. Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants. Free Radic Biol Med. 41:911-925.
56. Gautam SC, Gao X, and Dulchavsky S. 2007. Immunomodulation by curcumin. Adv Exp Med Biol. 595:321-341.
57. Giltay EJ, Hoogeveen EK, Elbers JMH, Gooren LJ, Asscheman H, and Stehouwer CD. 1998. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Letter to the Editor. Atherosclerosis. 139:197-198.
58. Grant KL and Schneider CD. 2000. Turmeric. Am J Health Syst Pharm. 57:1121-1122.
59. Groten JP, Butler W, Feron VJ, Kozianowski G, Renwick AG, and Walker R. 2000. An analysis of the possibility for health implications of joint actions and interactions between food additives. Reg Toxicol Pharmacol. 31:77-91.
60. Gukocvsky I, Reyes CN, Vaquero EC, Gukovskaya AS, and Pandol SJ. 2003. Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol. 284:G85-G95.
61. Hammamieh R, Sumaida D, Zhang X, Das R, and Jett M. 2007. Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism. BMC Cancer. 7:138.
62. Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T, Fujiyama Y, Mitsuyama K, Sata M et al. 2006. Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 4:1502-1506.
63. Holmes MD, Pollak MN, Willett WC, and Hankinson SE. 2002. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomark Prevent. 11:852-861.
64. Holt PR, Katz S, and Kirshoff R. 2005. Curcumin therapy in inflammatory bowel disease: A pilot study. Dig Dis Sci. 50:2191-2193.
65. Hong J, Bose M, Ju J, Ryu JH, Chen X, Sang S, Lee MJ, and Yang CS. 2004. Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis. 25:1671-1679.
66. Hour TC, Chen J, Huang CY, Guan JY, Lu SH, and Pu YS. 2002. Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate. 51:211-218.
67. Howie BJ and Shultz TD. 1985. Dietary and hormonal interrelationships among vegetarian Seventh-Day Adventists and nonvegetarian men. Am J Clin Nutr. 42:127-134.
68. Huang CY, Chen JH, Tsai CH, Kuo WW, Liu JY, and Chang YC. 2005. Regulation of extracellular signal-regulated protein kinase signaling in human osteosarcoma cells stimulated with nicotine. J Periodontal Res. 40:176-181.
69. Illek B, Lizarzaburu ME, Lee V, Nantz MH, Kurth MJ, and Fischer H. 2000. Structural determinants for activation and block of CFTR-mediated chloride currents by apigenin. Am J Physiol Cell Physiol. 279:C1838-C1844.
70. Jackson JK, Higo T, Hunter WL, and Burt HM. 2006. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res. 55:168-175.
71. Jagetia GC and Aggarwal BB. 2007. "Spicing up" of the immune system by curcumin. J Clin Immunol. 27:19-35.
72. Jovanovic SV, Boone CW, Steenken S, Trinoga M, and Kaskey RB. 2001. How curcumin preferentially works with water soluble antioxidants. J Am Chem Soc. 123:3064-3068.
73. Kalpana C and Menon VP. 2004. Modulatory effects of curcumin on lipid peroxidation and antioxidant status during nicotine-induced toxicity. Pol J Pharmacol. 56:581-586.
74. Kamal-Eldin A, Frank J, Razdan A, Tengblad S, Basu S, and Vessby B. 2000. Effects of dietary phenolic compounds on tocopherol, cholesterol and fatty acids in rats. Lipids. 35:427-435.
75. Kang BY, Song YJ, Kim KM, Choe YK, Hwang SY, and Kim TS. 1999. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol. 128:380-384.
76. Kanitkar M and Bhonde RR. 2008. Curcumin treatment enhances islet recovery by induction of heat shock response proteins, Hsp70 and heme oxygenase-1, during cryopreservation. Life Sci. 82:182-189.
77. Kaur G, Tirkey N, Bharrhan S, Chanana V, Rishi P, and Chopra K. 2006. Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents. Clin Exp Immunol. 145:313-321.
78. Kempaiah RK and Srinivasan K. 2002. Integrity of erythrocytes of hypercholesterolemic rats during spices treatment. Mol Cell Biochem. 236:155-161.
79. Kim DC, Kim SH, Choi BH, Hur EM, Kim SH, Choi BH, and Kim KT. 2005b. Curcuma longa extract protects against gastric ulcers by blocking H2 histamine receptors. Biol Pharm Bull. 28:2220-2224.
80. Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ, Moon DO, Lee CM, Ahn SC, Park YC, and Park YM. 2005a. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol. 174:8116-8124.
81. Kitani K, Yokozawa T, and Osawa T. 2004. Interventions in aging and age-associated pathologies by means of nutritional approaches. Ann N Y Acad Sci. 1019:424-426.
82. Kumar PA, Suryanarayana P, Reddy PY, and Reddy GB. 2005. Modulation of alpha-crystallin chaperone activity in diabetic rat lens by curcumin. Mol Vis. 11:561-568.
83. Kurd SK, Smith N, Vanvoorhees A, Troxel AB, Badmaev V, Seykora JT, and Gelfand JM. 2008. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial. J Am Acad Dermatol. 58:625-631.
84. Kurup VP, Barrios CS, Raju R, Johnson BD, Levy MB, and Fink JN. 2007. Immune response modulation by curcumin in a latex allergy model. Clin Mol Allergy. 5:1.
85. Kutluay SB, Doroghazi J, Roemer ME, and Triezenberg SJ. 2008. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology. 373:239-247.
86. Labbozzetta M, Notarbartolo M, Poma P, Giannitrapani L, Cervello M, Montalto G, and D'Alessandro N. 2006. Significance of autologous interleukin-6 production in the HA22 T/VGH cell model of hepatocellular carcinoma. Ann N Y Acad Sci. 1089:268-275.
87. Lal B, Kapoor AK, Agrawal PK, Asthana OP, and Srimal RC. 2000. Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother Res. 14(6):443-447.
88. Lal B, Kapoor AK, Asthana OP, Agrawal PK, Prasad R, Kumar P, and Srimal RC. 1999. Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res. 13:318-322.
89. Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, ParkYS, Kang WK, and Park K. 2005. Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun. 334:313-318.
90. Lev-Ari S, Starr A, Vexler A et al. 2006b. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res. 26:4423-4430.
91. Lev-Ari S, Strier L, Kazanov D, Elkayam O, Lichtenberg D, Caspi D, and Arber N. 2006a. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatol. 45:171-177.
92. Lev-Ari S, Vexler A, Starr A, Ashkenazy-Voghera M, Greif J, Aderka D, and Ben-Yosef R. 2007. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest. 25:411-418.
93. Li X and Liu X. 2005. Effect of curcumin on immune function of mice. J Huazhong Univ Sci Technolog Med Sci. 25:137-140.
94. Liao YF, Hung HC, Hour TC, Hsu PC, Kao MC, Tsay GJ, and Liu GY. 2008. Curcumin induces apoptosis through an ornithine decarboxylase-dependent pathway in human promyelocytic leukemia HL-60 cells. Life Sci. 82:367-375.
95. Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, Aggarwal BB, and Sood AK. 2007. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res. 13:3423-3430.
96. Liontas A and Yeger H. 2004. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res. 24:987-998.
97. López-Lázaro M, Willmore E, Jobson A, Gilroy KL, Curtis H, Padget K, and Austin CA. 2007. Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells. J Nat Prod. 70:1884-1888.
98. LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, Chakrabarti R, Srivatsan ES, and Wang MB. 2005. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res. 11:6994-7002.
99. Mahady GB, Pendland SL, Yun G, and Lu ZZ. 2002. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res. 22:4179-4182.
100. Malekinejad H, Scherpenisse P, and Bergwerff A. 2006. Naturally occurring estrogens in processed milk and in raw milk (from gestated cows). J Agric Food Chem. 54:9785-9791.
101. Manikandan P, Sumitra M, Aishwarya S, Manohar BM, Lokanadam B, and Puvanakrishnan R. 2004. Curcumin modulates free radical quenching in myocardial ischaemia in rats. Int J Biochem Cell Biol. 36:1967-1980.
102. Marín YE, Wall BA, Wang S, Namkoong J, Martino JJ, Suh J, Lee HJ, Rabson AB, Yang CS, Chen S, and Ryu JH. 2007. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res. 17:274-283.
103. McInnes IB, Gracie JA, Leung BP, Wei XQ, and Liew FY. 2000. Interleukin 18: A pleiotropic participant in chronic inflammation. Immunol Today. 21:312-315.
104. Meghana K, Sanjeev G, and Ramesh B. 2007. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: A prophylactic and protective role. Eur J Pharmacol. 577:183-191.
105. Mitra A, Chakrabarti J, Banerji A, Chatterjee A, and Das BR. 2006. Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2. J Environ Pathol Toxicol Oncol. 25:679-690.
106. Mosenthal AC, Xu D, and Deitch EA. 2002. Elemental and intravenous total parenteral nutrition diet-induced gut barrier failure is intestinal site specific and can be prevented by feeding nonfermentable fiber. Crit Care Med. 30:396-402.
107. Mundy GR. 2007. Osteoporosis and inflammation. Nutr Rev. 65:S147-S151.
108. Murugan P and Pari L. 2006a. Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. Life Sci. 79:1720-1728.
109. Murugan P and Pari L. 2006b. Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats. Basic Clin Pharmacol Toxicol. 99:122-127.
110. Murugan P and Pari L. 2007a. Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats. J Ethnopharmacol. 113:479-486.
111. Murugan P and Pari L. 2007b. Influence of etrahydrocurcumin on hepatic and renal functional markers and protein levels in experimental type 2 diabetic rats. Basic Clin Pharmacol Toxicol. 101:241-245.
112. Naidu KA and Thippeswamy NB. 2002. Inhibition of human low density lipoprotein oxidation by active principles from spices. Mol Cell Biochem. 229:19-23.
113. Ohadshi Y, Tsuchia Y, Koizumi K, Sakurai H, and Saiki I. 2003. Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncol. 65:250-258.
114. Okunieff P, Xu J, Hu D, Liu W, Zhang L, Morrow G, Pentland A, Ryan JL, and Ding I. 2006. Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys. 65:890-898.
115. Olszanecki R, Gebska A, and Korbut R. 2007. The role of haem oxygenase-1 in the decrease of endothelial intercellular adhesion molecule-1 expression by curcumin. Basic Clin Pharmacol Toxicol. 101:411-415.
116. Padmaja S and Raju TN. 2004. Antioxidant effects in selenium induced cataract of Wistar rats. Ind J Exp Biol. 42:601-603.
117. Pahl HL. 1999. Activators and target genes of Rel/ NF-κB transcription factors. Oncogene. 18:6853-6866.
118. Panchatcharam M, Miriyala S, Gayathri VS, and Suguna L. 2006. Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species. Mol Cell Biochem. 290:87-96.
119. Pandya U, Saini MK, Jin GF, Awasthi S, Godley BF, and Awasthi YC. 2000. Dietary curcumin prevents ocular toxicity of naphthalene in rats. Toxicol Lett. 115:195-204.
120. Pari L and Murugan P. 2007a. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail. 29:881-889.
121. Pari L and Murugan P. 2007b. Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin-induced diabetic rats. J Med Food. 10:323-329.
122. Pari L and Murugan P. 2007c. Changes in glycoprotein components in streptozotocin-nicotinamide induced type 2 diabetes: Influence of tetrahydrocurcumin from Curcuma longa. Plant Foods Hum Nutr. 62:25-29.
123. Pari L and Murugan P. 2007d. Influence of tetrahydrocurcumin on tail tendon collagen contents and its properties in rats with streptozotocin-nicotinamide-induced type 2 diabetes. Fundam Clin Pharmacol. 21:665-671.
124. Parodi FE, Mao D, Ennis TL, Pagano MB, and Thompson RW. 2006. Oral administration of diferuloylmethane (curcumin) suppresses proinflammatory cytokines and destructive connective tissue remodeling in experimental abdominal aortic aneurysms. Ann Vasc Surg. 20:360-368.
125. Pérez-Arriaga L, Mendoza-Magaña ML, Cortés-Zárate R, Corona-Rivera A, Bobadilla-Morales L, Troyo-Sanromán R, and Ramírez-Herrera MA. 2006. Cytotoxic effect of curcumin on Giardia lamblia trophozoites. Acta Trop. 98:152-161.
126. Punithavatihi DP, Venkatesan N, and Babu M. 2003. Protective effects of curcumin against amimodarone-induced pulmonary fibrosis in rats. Br J Pharmacol. 139:1342-1350.
127. Quiles JL, Mesa MD, Ramírez-Tortosa CL, Aguilera CM, Battino M, Gil A, and Ramírez-Tortosa MC. 2002. Curcuma longa extraxt supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Throm Vasc Biol. 22:1225-1231.
128. Raju TN, Kumar CS, Kanth VR, Ramana BV, Reddy PU, Suryanarayana P, and Reddy GB. 2006. Cumulative antioxidant defense against oxidative challenge in galactose-induced cataractogenesis in Wistar rats. Indian J Exp Biol. 44(9):733-739.
129. Ram A, Das M, and Ghosh B. 2003. Curcumin attenuates allergen-induced hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull. 26:1021-1024.
130. Ramaswami G, Chai H, Yao Q, Lin PH, Lumsden AB, and Chen C. 2004. Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg. 40:1216-1222.
131. Rattan SI and Ali RE. 2007. Hormetic prevention of molecular damage during cellular aging of human skin fibroblasts and keratinocytes. Ann N Y Acad Sci. 1100:424-430.
132. Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN. 2005. Curcumin for malaria therapy. Biochem Biophys Res Commun. 326:472-474.
133. Reyes-Gordillo K, Segovia J, Shibayama M, Vergara P, Moreno MG, and Muriel P. 2007. Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim Biophys Acta. 1770:989-996.
134. Sajithlal GB, Chithra P, and Chandrakasan G. 1998. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol. 56:1607-1614.
135. Sakanaka S and Okada Y. 2004. Inhibitory effects of green tea polyphenols on the production of a virulence factor of the periodontal-disease-causing anaerobic bacterium Porphyromonas gingivalis. J Agric Food Chem. 52:1688-1692.
136. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P,Badmaev V, and Aggarwal BB. 2007. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 28:1765-1773.
137. Satoskar RR, Shah SJ, and Shenoy SG. 1986. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol. 24:651-654.
138. Shainani-Wu N. 2003. Safety and anti-inflammatory activity of curcumin: A component of turmeric (Curcuma longa). J Altern Complement Med. 9:161-168.
139. Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, and Mobasheri A. 2007. Suppression of NF-kB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol. 73:1434-1445.
140. Shankar S and Srivastava RK. 2007. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol. 30:905-918.
141. Shapiro H, Ashkenazi M, Weizman N, Shahmurov M, Aeed H, and Bruck R. 2006. Curcumin ameliorates acute thioacetamide-induced hepatotoxicity. J Gastroenterol Hepatol. 21:358-366.
142. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, and Talalay P. 1998. Human metabolism and excretion of cancer chemoprotective glucoisonolates and isothiocyanates of cruciferious vegetables. Cancer Epidemiol Biomarkers Prev. 7:1091-1100.
143. Sharma C, Kaur J, Shishodia S, Aggarwal BB, and Ralhan R. 2006. Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology. 228:1-15.
144. Sharma RA, Ireson CR, Verschoyle RD, Hill KA, Williams ML, Leuratti C, Manson MM, Marnett LJ, Steward WP, and Gescher A. 2001. Effects of dietary curcumin on glutathione S-transferase and malonaldehyde-DNA adducts in rat liver and colonic mucosa: Relationship with drug levels. Clin Cancer Res. 7:1452-1458.
145. Shen SQ, Zhang Y, Xiang JJ, and Xiong CL. 2007. Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol. 13:1953-1961.
146. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, and Srinivas PS. 1998. Influence of peperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64:1167-1172.
147. Shpitz B, Giladi N, Sagiv E, Lev-Ari S, Liberman E, Kazanov D, and Arber N. 2006. Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model. Digestion. 74(3-4): 140-144.
148. Siddiqui AM, Cui X, Wu R, Dong W, Zhou M, Hu M, Simms HH, and Wang P. 2006. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med. 34:1874-1882.
149. Siddiqui IA, Afaq F, Adhami VM, Ahmad N, and Mukhtar H. 2004. Antioxidants of the beverage tea in promotion of human health. Antioxid Redox Signal. 6:571-582.
150. Singer AJ, McClain SA, Romanov A, Rooney J, and Zimmerman T. 2007. Curcumin reduces burn progression in rats. Acad Emerg Med. 14:1125-1129.
151. Siwak DR, Shishodia S, Aggarwal BB, and Kurzrock R. 2005. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer. 104:879-890.
152. Srinisan P and Libbus B. 2004. Mining MEDLINE for implicit links between dietary substances and diseases. Bioinformatics. 20(Suppl 1):1290-1296.
153. Steward WP and Gescher AJ. 2008. Curcumin in cancer management: Recent results of analogue design and clinical studies and desirable future research. Mol Nutr Food Res. 52:1005:1009.
154. Stolina M, Sharma S, Lin Y, Dohadwala M, Gardner B, Luo J, Zhu L, Kronenberg M, Miller PW, Portanova J, Lee JC, and Dubinett SM. 2000. Specific inhibition of cyclooxygenase-2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol. 164:361-370.
155. Surh Y-J, Chun K-S, Cha H-H, Han SS, Keum YS, Park KK, and Lee SS. 2001. Molecular mechanisms underlying chemo-preventive activities of anti-inflammatory phytochemicals: Downregulation of COX-2 and iNOS through suppression of NF-κB activation. Mut Res. 480-481:243-268.
156. Suryanarayana P, Krishnaswamy K, and Reddy B. 2003. Effects on galactose-induced cataractogenesis in rats. Molecular Vision. 9:223-230.
157. Suzuki M, Nakamura T, Iyoki S, Fujiwara A, Watanabe Y, Mohri K, Isobe K, Ono K, and Yano S. 2005. Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol Pharm Bull. 28:1438-1443.
158. Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, and Sharma AV. 2005. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem. 280:9409-9415.
159. Taneja R, Parodo J, Jia SH, Kapus A, Rotstein OD, and Marshall JC. 2004. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med. 32:1460-1469.
160. Thapliyal R, Dolas SS, Pakhale SS, and Maru GB. 2004. Evaluation of DNA damage in mice topically exposed to total particulate matter from mainstream and sidestream smoke from cigarettes and bidis. Mutagenesis. 19:413-421.
161. Thapliyal R and Maru GB. 2001. Inhibition of cytochrome P450 isoenzymes by curcumins in vitro and in vivo. Food Chem Toxicol. 39:541-547.
162. Thiemermann C. 2006. The spice of life: Curcumin reduces the mortality associated with experimental sepsis. Crit Care Med. 34:2009-2011.
163. Vanisree AJ and Ramanan R. 2007. In vitro assessment of curcumin against murine neuroblastoma cells. Neuro Endocrinol Lett. 28:204-212.
164. Wallace JM. 2002. Nutritional and botanical modulation of the inflammatory cascade-Eicosanoids, cyclooxygenases and lipooxygenases-As an adjunct in cancer therapy. Integr Cancer Ther. 1:7-37.
165. Walters DK, Muff R, Langsam B, Born W, and Fuchs B. 2008. Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest New Drugs. 26:289-297.
166. World Health Organization. 2003. Process for a global strategy on diet, physical activity and health. WHO, Geneva.
167. Xia Y, Jin L, Zhang B, Xue H, Li Q, and Xu Y. 2007. The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7human breast carcinoma cells. Life Sci. 80:2161-2169.
168. Xu D, Lu Q, and Deitch EA. 1998. Elemental diet-induced bacterial translocation associated with systemic and intestinal immune suppression. J Parenter Enteral Nutr JPEN. 22:37-41.
169. Xu PH, Long Y, Dai F, and Liu ZL. 2007. The relaxant effect of curcumin on porcine coronary arterial ring segments. Vascul Pharmacol. 47:25-30.
170. Zhang F, Altorki NK, Mestre JR, Subbaramaiah K, and Dannenberg AJ. 1999. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis. 20:445-451.
171. Zhang HG, Kim H, Liu C, Yu S, Wang J, Grizzle WE, Kimberly RP, and Barnes S. 2007. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim Biophys Acta. 1773:1116-1123.
172. Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, and Rosenthal M. 2006. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 10(1):1-7.